ArticleViruses2022

Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus.

Syed Faraz Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.